Showing results (71-80 of 1,057) with videos related to
Sort By:
Pageof 106
Alzheimer'S & Dementia (New York, N. Y.)|August 8, 2024
Pooling Alzheimer's disease clinical trial data to develop personalized medicine approaches is easier said than done: A proof-of-principle study and call to actionMark A Dubbelman, Eleonora M Vromen, Betty M Tijms, et al.Alzheimer'S & Dementia (New York, N. Y.)|August 15, 2024
APOLLOE4 Phase 3 study of oral ALZ-801/valiltramiprosate in APOE ε4/ε4 homozygotes with early Alzheimer's disease: Trial design and baseline characteristicsSusan Abushakra, Anton P Porsteinsson, Marwan Sabbagh, et al.Alzheimer'S & Dementia (New York, N. Y.)|August 13, 2024
Rural-Urban mild cognitive impairment comparison in West Michigan through EHRXiaodan Zhang, Martin Witteveen-Lane, Christine Skovira, et al.Alzheimer'S & Dementia (New York, N. Y.)|June 25, 2024
Sex, gender, sexual orientation, and more: Sexual diversity in Alzheimer's research needs a new lens to achieve inclusive research and generalizable resultsShana D Stites, Beans VelocciAlzheimer'S & Dementia (New York, N. Y.)|December 22, 2022
Apathy and APOE in mild behavioral impairment, and risk for incident dementiaDaniella Vellone, Maryam Ghahremani, Zahra Goodarzi, et al.Alzheimer'S & Dementia (New York, N. Y.)|November 14, 2019
The TOMMORROW study: Design of an Alzheimer's disease delay-of-onset clinical trialDaniel K Burns, Carl Chiang, Kathleen A Welsh-Bohmer, et al.Alzheimer'S & Dementia (New York, N. Y.)|December 7, 2020
The impact of SARS-CoV-2 in dementia across Latin America: A call for an urgent regional plan and coordinated responseAgustin Ibanez, Hernando Santamaria-Garcia, Alejandra Guerrero Barragan, et al.Alzheimer'S & Dementia (New York, N. Y.)|December 7, 2020
Differentiating among stages of cognitive impairment in aging: Version 3 of the Uniform Data Set (UDS) neuropsychological test battery and MoCA index scoresHiroko H Dodge, Felicia C Goldstein, Nicole I Wakim, et al.Alzheimer'S & Dementia (New York, N. Y.)|December 7, 2020
Statin therapy and risk of Alzheimer's and age-related neurodegenerative diseasesGeorgina Torrandell-Haro, Gregory L Branigan, Francesca Vitali, et al.Alzheimer'S & Dementia (New York, N. Y.)|December 7, 2020
Model organism development and evaluation for late-onset Alzheimer's disease: MODEL-ADAdrian L Oblak, Stefania Forner, Paul R Territo, et al.Pageof 106